Found: 2
Select item for more details and to access through your institution.
Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Preclinical evaluation of an anti-α5β1 integrin antibody as a novel anti-angiogenic agent.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2006, v. 5, n. 4, p. 273
- By:
- Publication type:
- Article